Overview

Endothelial Dysfunction and Diabetes

Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to progress in the understanding of the early retinal vascular and neural abnormalities in patients with diabetes, using a new device, the Dynamic Vessel Analyzer. The Dynamic Vessel Analyzer allows to measure the diameter of the retinal vessels and to assess how it varies in presence of various stimuli. Then, we will be able to assess if a vascular and/or a neural dysfunction is present early in patient with diabetes.
Details
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Treatments:
Acetylcholine
Glucuronyl glucosamine glycan sulfate
Nitroglycerin
Oxymetazoline
Phenylephrine